Cell Repair Plus (CRP)

What Exactly Is Cell Repair Plus?

The term stem cell can make it sound as though all stem cells are the same.

They are not.

Stem cells come from different sources and possess different biological characteristics. Cell Repair Plus uses umbilical cord mesenchymal stem cells.

Mesenchymal stem cells have been extensively studied in regenerative medicine because of their ability to interact with surrounding cells and participate in biological processes associated with tissue repair, immune regulation, and regeneration (Hoang et al., 2022; Naji et al., 2019).

Umbilical cord derived stem cells have also attracted scientific interest because of characteristics associated with their perinatal origin, including proliferative capacity and relatively low immunogenicity compared with some other sources (Jamali et al., 2024; Thomaidou et al., 2023).

So what does that mean for you?

It means the potential role of these cells is not simply about replacing damaged cells.

It is also about what the cells may communicate to the cells already in your body.

Your Cells Are Constantly Talking

Your tissues are not collections of isolated cells.

Cells constantly exchange signals that influence how neighboring cells behave.

One of the important mechanisms being studied in stem cell therapy is paracrine signaling.

In simple terms, paracrine signaling is a form of local cellular communication. A cell releases biological molecules that can influence nearby cells.

Stem cells can release a range of biological factors, including growth factors, cytokines, chemokines, and extracellular vesicles. These signals may influence processes involving inflammation, immune responses, cell survival, blood vessel formation, and tissue repair (Naji et al., 2019; Lotfy et al., 2023).

Think of it like a conversation inside the tissue.

This is why research increasingly looks beyond the idea that stem cells simply "turn into" replacement tissue.

Their potential effects may also involve the biological signals they release and their interactions with surrounding cells (Lotfy et al., 2023; Naji et al., 2019).

So What Happens After the Cells Enter Your Body?

At AIM+, Cell Repair Plus is generally administered intravenously (IV) for holistic cellular and tissue regeneration. In certain cases, local injection may also be advised by the physician when appropriate.

The approach is broader than simply thinking of the cells as replacements for damaged tissue.

Research suggests that stem cells can interact with the body's biological environment through multiple mechanisms, including communication between cells and modulation of inflammatory and immune pathways (Hoang et al., 2022; Naji et al., 2019).

At AIM+, the stem cell secretome is also incorporated into the approach. The secretome refers to the collection of biological factors released by stem cells, including soluble signaling molecules and extracellular vesicles. These components can participate in communication between cells and may influence processes involved in tissue repair, immune regulation, and regeneration (Daneshmandi et al., 2020; Da Silva et al., 2025; Sousa et al., 2026).

These biological signals can help facilitate cellular communication toward areas that need repair, complementing the broader regenerative purpose of the treatment.

The important distinction is this:

The cells are not simply expected to travel through the body and automatically rebuild every damaged structure they encounter.

Instead, the approach involves cellular communication and interaction with the body's existing biological environment.

The potential value of cellular therapy may not lie in the cells acting alone.

It may lie in how they interact with the environment around them.

When Cellular Communication Supports Tissue Repair

Now we can follow the process one step further.

If stem cells communicate with surrounding cells and influence biological signaling, what happens next?

Research is investigating how these signals may affect processes involved in tissue maintenance and repair.

For example, stem cell related signaling has been associated in research with:

• Modulation of inflammatory responses
• Immune regulation
• Support of cell survival
• Angiogenesis, or the formation of new blood vessels
• Migration and activity of cells involved in tissue repair

(Naji et al., 2019; Hetta et al., 2024; Ma et al., 2023).

Research in diabetic wound healing provides one example. A comprehensive review reported evidence involving re-epithelialization, angiogenesis, inflammation, and immune modulation in stem cell research, while also emphasizing ongoing challenges involving efficacy, safety, and treatment optimization (Hetta et al., 2024).

Experimental research involving umbilical cord stem cell derived secretome and extracellular vesicles has investigated effects on processes such as cell migration, angiogenesis, inflammation, and tissue repair, although much of the evidence remains preclinical (Ma et al., 2023; Da Silva et al., 2025).

What does that mean for you?

The goal is not to promise that damaged tissue will simply "grow back."

The more accurate way to understand regenerative medicine is that researchers are investigating whether cellular therapies can support biological processes that contribute to tissue maintenance, protection, and repair.

Why Umbilical Cord Mesenchymal Stem Cells?

Not all stem cells come from the same place.

Stem cells can be obtained from different sources, each with distinct biological characteristics and potential applications (Lotfy et al., 2023). These differences are summarized in Table 1.

Table 1 | Umbilical Cord Mesenchymal Stem Cells Compared With Other Stem Cell Sources

Umbilical cord mesenchymal stem cells are of particular interest because they originate from perinatal tissue and have demonstrated characteristics such as high proliferative capacity and relatively low immunogenicity in research settings (Jamali et al., 2024; Thomaidou et al., 2023).

This does not mean that umbilical cord stem cells are universally superior for every disease.

It means their biological characteristics make them an important area of investigation in regenerative medicine.

Why Is Stem Cell Therapy Getting So Much Attention?

The interest is no longer limited to laboratory research.

Human studies have investigated stem cell based approaches across different conditions, including neurological disorders, inflammatory diseases, wound healing, and musculoskeletal conditions (Hoang et al., 2022).

For example, a 2024 Phase I/II clinical study investigated umbilical cord derived stem cells in people with multiple sclerosis. The researchers reported that participants tolerated the cellular therapy without serious adverse events and observed improvements in several measures during follow up. However, the authors also emphasized the need for larger studies to further evaluate these findings and establish appropriate protocols (Jamali et al., 2024).

A 2025 systematic review and meta-analysis of umbilical cord mesenchymal stem cell treatment for knee osteoarthritis included eight studies involving 688 participants. Some analyses found improvements in pain and function, particularly in certain dose groups, but the overall evidence was heterogeneous and further standardized studies were recommended (Lohrasbi et al., 2025).

This is an important distinction:

Promising research is not the same as a guaranteed treatment outcome.

The evidence can be encouraging while still evolving.

Who May Be Considered for Cell Repair Plus?

This is where clinical practice and scientific research must be kept separate.

At AIM+, Cell Repair Plus may be considered for generally well individuals who seek to optimize their health and well-being, as well as selected patients in the context of conditions such as:

• Neurodegenerative conditions, including Alzheimer's disease and Parkinson's disease
• Autoimmune and inflammatory conditions, including rheumatoid arthritis, systemic lupus erythematosus, psoriatic arthritis, and others
• Early-stage chronic kidney disease
• Cardiomyopathy
• Other degenerative conditions
• Other conditions related to changes associated with aging

These represent clinical considerations at AIM+, not a statement that Cell Repair Plus has been proven to treat or cure every condition listed.

Research involving stem cells spans many of these areas, but the strength of evidence varies substantially by condition, treatment protocol, cell source, dose, and patient population (Hoang et al., 2022).

That is why one question matters more than simply asking, "What disease do I have?"

Could this approach be appropriate for me?

How Does AIM+ Determine If You Are Suitable?

Regenerative medicine should not begin with a diagnosis alone.

It should begin with understanding the individual patient and determining whether the treatment is appropriate for that person's circumstances.

An appropriate medical work-up will be requested by your physician to ensure that the benefits of stem cell treatment will be maximized.

At minimum, blood tests may be requested, while imaging may also be requested by your physician when appropriate.

The specific work-up may depend on the individual patient's circumstances and the physician's clinical assessment.

This allows the physician to determine the most appropriate approach rather than relying on a fixed checklist applied to every patient.

Where Do the Cells Come From?

The stem cells used for Cell Repair Plus are sourced from California, USA.

The source, preparation, characterization, and quality control of cellular products are important considerations in cellular therapy.

Research emphasizes that stem cell products can vary according to their source, donor, culture conditions, and preparation (Lotfy et al., 2023).

For patients considering cellular therapy, understanding the source of the cells is an important part of making an informed decision.

What Should You Realistically Expect?

Perhaps the most important thing to understand about regenerative medicine is that biology does not work like a light switch.

A treatment does not automatically translate into immediate tissue regeneration.

Cellular responses involve multiple biological processes, and the effects of stem cell therapy can depend on the cells themselves, the surrounding tissue environment, the condition being addressed, and the treatment protocol. Researchers continue to investigate the exact mechanisms and the factors that determine clinical response (Lotfy et al., 2023; Hoang et al., 2022).

This is also why research has not established one universal dose, protocol, or outcome for every patient and every condition.

Regeneration is a process.

And processes take time.

The One Thing to Remember

Cellular rejuvenation is complex and takes time.

Regenerative medicine is not about promising overnight transformation.

It is about understanding the body's biology, understanding the cells being used, and carefully considering how cellular therapy may fit into an individual's health journey.